| Original language | English |
|---|---|
| Article number | 20 |
| Journal | BMC Musculoskeletal Disorders |
| Volume | 18 |
| Number of pages | 11 |
| ISSN | 1471-2474 |
| DOIs | |
| Publication status | Published - 19 Jan 2017 |
| MoE publication type | A1 Journal article-refereed |
Fields of Science
- Bone mu CT
- Bone-muscle interactions
- TGF-beta s
- Animal models
- Exercise
- MUSCLE PROTEIN-SYNTHESIS
- MDX MICE
- OXIDATIVE CAPACITY
- MYOSTATIN
- EXERCISE
- DENSITY
- METAANALYSIS
- DEFICIENCY
- PREVENTS
- BLOCKING
- 3126 Surgery, anesthesiology, intensive care, radiology
- 3121 Internal medicine
Cite this
}
Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy. / Puolakkainen, Tero; Ma, Hongqian; Kainulainen, Heikki; Pasternack, Arja; Rantalainen, Timo; Ritvos, Olli; Heikinheimo, Kristiina; Hulmi, Juha; Kiviranta, Riku.
In: BMC Musculoskeletal Disorders, Vol. 18, 20, 19.01.2017.Research output: Contribution to journal › Article › Scientific › peer-review
TY - JOUR
T1 - Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy
AU - Puolakkainen, Tero
AU - Ma, Hongqian
AU - Kainulainen, Heikki
AU - Pasternack, Arja
AU - Rantalainen, Timo
AU - Ritvos, Olli
AU - Heikinheimo, Kristiina
AU - Hulmi, Juha
AU - Kiviranta, Riku
PY - 2017/1/19
Y1 - 2017/1/19
KW - Bone mu CT
KW - Bone-muscle interactions
KW - TGF-beta s
KW - Animal models
KW - Exercise
KW - MUSCLE PROTEIN-SYNTHESIS
KW - MDX MICE
KW - OXIDATIVE CAPACITY
KW - MYOSTATIN
KW - EXERCISE
KW - DENSITY
KW - METAANALYSIS
KW - DEFICIENCY
KW - PREVENTS
KW - BLOCKING
KW - 3126 Surgery, anesthesiology, intensive care, radiology
KW - 3121 Internal medicine
U2 - 10.1186/s12891-016-1366-3
DO - 10.1186/s12891-016-1366-3
M3 - Article
VL - 18
JO - BMC Musculoskeletal Disorders
JF - BMC Musculoskeletal Disorders
SN - 1471-2474
M1 - 20
ER -